Bengaluru, February 23 Karnataka's BioEconomy is projected to reach USD 39.2 billion in 2025, marking strong growth from previous years and reaffirming the state's leadership position nationally, according to an official report released on Monday.
The Karnataka Innovation and Technology Society (KITS), under the Department of Electronics, IT, Biotechnology and Science & Technology, unveiled the Karnataka BioEconomy Report 2025 in collaboration with the Association of Biotechnology Led Enterprises.
The report, released by IT Minister Priyank Kharge, stated that the state contributes around 21 per cent of India's BioEconomy and accounts for over 10 per cent of Karnataka's GSDP.
According to the report, the BioEconomy has expanded from USD 31.0 billion in 2023, reflecting 26.5 per cent cumulative growth, and is now adding nearly USD 10 billion every quarter to the state's GDP.
BioPharma remains the dominant sector, with over 40 per cent share (approximately USD 16.44 billion), driven by biologics, biosimilars, vaccines, and diagnostics, it stated.
"BioIndustrial biotechnology has emerged as the fastest-growing segment (approximately USD 11.46 billion, around 29 per cent share), led by fermentation-based industries, biofuels, enzymes, and sustainable materials," the report stated.
BioServices account for approximately 25.8 per cent share, while BioAgri contributes to sustainable agriculture and input innovation, it added.
The report indicated that BioEconomy growth is becoming increasingly multi-regional. While Bengaluru Urban accounts for about 54 per cent of the state's BioEconomy, Mysuru contributes around 8.7 per cent, while Belagavi and Dakshina Kannada together account for over 9 per cent. Northern districts remain the Agri-biotechnology belt.
As many as 218 new biotech startups were established in 2025, bringing the cumulative total to 1,451 startups, with over 75 per cent focused on life sciences and health-tech. Bengaluru accounts for about 54 per cent of startups, it stated.
Between January 2024 and October 2025, the report stated that Karnataka attracted USD 1.14 billion across around 40 deals spanning BioPharma, MedTech, precision fermentation, digital health, and AgriBio.
Minister Kharge said, "With our BioEconomy crossing USD 39 billion and contributing over 10 per cent to our GSDP, biotechnology is no longer confined to laboratories—it is now a central driver of economic growth, industrial innovation, and societal impact."
He said that the state government's focus is on building a full-spectrum biomanufacturing economy by supporting deep-tech startups, strengthening innovation infrastructure, and ensuring that growth reaches beyond Bengaluru to every region of the state.